Cargando…

Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice

This study aimed to explore the protective roles of malvidin in life-threatened sepsis-associated encephalopathy (SAE) and illustrate the underlying mechanism. SAE mice models were developed and treated with malvidin for subsequently protective effects evaluation. Malvidin restored neurobehavioral r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Panpan, Li, Xiaomin, Yang, Qiankun, Lu, Yingzhi, Wang, Guanglu, Yang, Haitao, Dong, Jingquan, Zhang, Honggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868257/
https://www.ncbi.nlm.nih.gov/pubmed/36699054
http://dx.doi.org/10.3389/fphar.2022.1038802
_version_ 1784876492524617728
author Zhao, Panpan
Li, Xiaomin
Yang, Qiankun
Lu, Yingzhi
Wang, Guanglu
Yang, Haitao
Dong, Jingquan
Zhang, Honggang
author_facet Zhao, Panpan
Li, Xiaomin
Yang, Qiankun
Lu, Yingzhi
Wang, Guanglu
Yang, Haitao
Dong, Jingquan
Zhang, Honggang
author_sort Zhao, Panpan
collection PubMed
description This study aimed to explore the protective roles of malvidin in life-threatened sepsis-associated encephalopathy (SAE) and illustrate the underlying mechanism. SAE mice models were developed and treated with malvidin for subsequently protective effects evaluation. Malvidin restored neurobehavioral retardation, declined serum S100β and NSE levels, sustained cerebrum morphological structure, improved blood-brain barrier integrity with elevated tight junction proteins, and decreased evans blue leakage, and finally protect SAE mice from brain injury. Mechanistically, malvidin prevented cerebrum from mitochondrial dysfunction with enhanced JC-1 aggregates and ATP levels, and ROS accumulation with decreased lipid peroxidation and increased antioxidant enzymes. UCP2 protein levels were found to be decreased after LPS stimulation in the cerebrum and BV-2 cells, and malvidin recovered its levels in a ROS dependent manner. In vivo inhibition of UCP2 with genipin or in vitro interference with siRNA UCP2 both disrupted the mitochondrial membrane potential, decreased ATP levels and intensified DCF signals, being a key target for malvidin. Moreover, dorsomorphin block assays verified that malvidin upregulated UCP2 expression through phosphorylating AMPK in SAE models. Also, malvidin alleviated SAE progression through inhibition of ROS-dependent NLRP3 inflammasome activation mediated serum pro-inflammatory cytokines secretion and mitochondrial pathway mediated apoptosis with weakened apoptosis body formation and tunel positive signals, and decreased Bax, cytochrome C, caspase-3 and increased Bcl-2 protein levels. Overall, this study illustrated that malvidin targeted AMPK-α/UCP2 axis to restore LPS-induced mitochondrial dysfunction and alleviate ROS accumulation, which further inhibits NLRP3 inflammasome activation and mitochondrial apoptosis in a ROS dependent way, and ultimately protected SAE mice, providing a reference for the targeted development of SAE prophylactic approach.
format Online
Article
Text
id pubmed-9868257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98682572023-01-24 Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice Zhao, Panpan Li, Xiaomin Yang, Qiankun Lu, Yingzhi Wang, Guanglu Yang, Haitao Dong, Jingquan Zhang, Honggang Front Pharmacol Pharmacology This study aimed to explore the protective roles of malvidin in life-threatened sepsis-associated encephalopathy (SAE) and illustrate the underlying mechanism. SAE mice models were developed and treated with malvidin for subsequently protective effects evaluation. Malvidin restored neurobehavioral retardation, declined serum S100β and NSE levels, sustained cerebrum morphological structure, improved blood-brain barrier integrity with elevated tight junction proteins, and decreased evans blue leakage, and finally protect SAE mice from brain injury. Mechanistically, malvidin prevented cerebrum from mitochondrial dysfunction with enhanced JC-1 aggregates and ATP levels, and ROS accumulation with decreased lipid peroxidation and increased antioxidant enzymes. UCP2 protein levels were found to be decreased after LPS stimulation in the cerebrum and BV-2 cells, and malvidin recovered its levels in a ROS dependent manner. In vivo inhibition of UCP2 with genipin or in vitro interference with siRNA UCP2 both disrupted the mitochondrial membrane potential, decreased ATP levels and intensified DCF signals, being a key target for malvidin. Moreover, dorsomorphin block assays verified that malvidin upregulated UCP2 expression through phosphorylating AMPK in SAE models. Also, malvidin alleviated SAE progression through inhibition of ROS-dependent NLRP3 inflammasome activation mediated serum pro-inflammatory cytokines secretion and mitochondrial pathway mediated apoptosis with weakened apoptosis body formation and tunel positive signals, and decreased Bax, cytochrome C, caspase-3 and increased Bcl-2 protein levels. Overall, this study illustrated that malvidin targeted AMPK-α/UCP2 axis to restore LPS-induced mitochondrial dysfunction and alleviate ROS accumulation, which further inhibits NLRP3 inflammasome activation and mitochondrial apoptosis in a ROS dependent way, and ultimately protected SAE mice, providing a reference for the targeted development of SAE prophylactic approach. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868257/ /pubmed/36699054 http://dx.doi.org/10.3389/fphar.2022.1038802 Text en Copyright © 2023 Zhao, Li, Yang, Lu, Wang, Yang, Dong and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhao, Panpan
Li, Xiaomin
Yang, Qiankun
Lu, Yingzhi
Wang, Guanglu
Yang, Haitao
Dong, Jingquan
Zhang, Honggang
Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title_full Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title_fullStr Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title_full_unstemmed Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title_short Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
title_sort malvidin alleviates mitochondrial dysfunction and ros accumulation through activating ampk-α/ucp2 axis, thereby resisting inflammation and apoptosis in sae mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868257/
https://www.ncbi.nlm.nih.gov/pubmed/36699054
http://dx.doi.org/10.3389/fphar.2022.1038802
work_keys_str_mv AT zhaopanpan malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT lixiaomin malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT yangqiankun malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT luyingzhi malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT wangguanglu malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT yanghaitao malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT dongjingquan malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice
AT zhanghonggang malvidinalleviatesmitochondrialdysfunctionandrosaccumulationthroughactivatingampkaucp2axistherebyresistinginflammationandapoptosisinsaemice